Lixte Biotechnology Holdings Inc Stock Ownership - Who owns Lixte Biotechnology Holdings?

Insider buying vs selling

Have Lixte Biotechnology Holdings Inc insiders been buying or selling?
Rene BernardsDirector2023-10-035,527$2.51
Rene BernardsDirector2023-10-035,527$2.51
Rene BernardsDirector2023-10-035,527$2.51
Der Baan Bastiaan Jeroen VanPresident and CEO2023-10-0310,000$2.80
Rene BernardsDirector2023-10-024,473$2.29
Rene BernardsDirector2023-10-024,473$2.29
Rene BernardsDirector2023-10-024,473$2.29

1 of 1

LIXT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LIXT insiders and whales buy or sell their stock.

LIXT Shareholders

What type of owners hold Lixte Biotechnology Holdings Inc stock?
John S. Kovach68.47%1,540,183$3.88MInsider
Glenn Krinsky65.58%1,474,998$3.72MInsider
Gil Schwartzberg52.30%1,176,388$2.96MInsider
Robert 1. Greenberg44.21%994,299$2.51MInsider
Philip F. Palmedo4.76%107,056$269.78kInsider
Hightower Advisors LLC4.42%99,432$250.57kInstitution
Stephen J. Forman3.33%74,804$188.51kInsider
Yun Yen2.34%52,632$132.63kInsider
Eric Forman1.72%38,598$97.27kInsider
Rene Bernards1.11%25,000$63.00kInsider

1 of 2

LIXT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LIXT2.45%97.55%Net Buying
KTTA0.27%99.73%Net BuyingNet Buying
ADIL3.67%96.33%Net Buying
CELZ7.87%3.96%Net Buying

Lixte Biotechnology Holdings Stock Ownership FAQ

Who owns Lixte Biotechnology Holdings?

Lixte Biotechnology Holdings (NASDAQ: LIXT) is owned by 6.15% institutional shareholders, 244.58% Lixte Biotechnology Holdings insiders, and 0.00% retail investors. John S. Kovach is the largest individual Lixte Biotechnology Holdings shareholder, owning 1.54M shares representing 68.47% of the company. John S. Kovach's Lixte Biotechnology Holdings shares are currently valued at $3.77M.

If you're new to stock investing, here's how to buy Lixte Biotechnology Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.